Erythrocyte-binding therapeutics
US-9850296-B2 · Dec 26, 2017 · US
US11001825B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11001825-B2 |
| Application number | US-201916255973-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 24, 2019 |
| Priority date | Dec 15, 2017 |
| Publication date | May 11, 2021 |
| Grant date | May 11, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure discloses a thermophilic L-asparaginase mutant and screening and fermentation methods thereof, and belongs to the field of gene engineering, enzyme engineering and fermentation engineering. In Bacillus subtilis 168, a Pyrococcus yayanosii CH1-derived L-asparaginase encoding gene is used as a template, and a mutation library is constructed by an error-prone PCR (epPCR) technology. A mutant strain with improved specific enzyme activity is screened through a high-flux screening method of synchronous cell disruption and enzyme activity measurement. Mutated residues included in a positive mutant are analyzed to construct a composite mutant strain S17G/A90S/R156S/K272A with improved specific enzyme activity and specific enzyme activity of 3108 U/mg. An expression quantity of the composite mutant strain in the Bacillus subtilis 168 is increased through measures of a strong promoter P43 and RBS optimization. Finally, the Bacillus subtilis 168 with a gene of the L-asparaginase composite mutant strain is subjected to enzyme production fermentation in a 5 L fermentation tank through culture medium optimization and pH and feeding coupling strategies. The enzyme activity yield of the L-asparaginase is up to 6453+/−127 U/mL.
Opening claim text (preview).
What is claimed is: 1. A thermophilic L-asparaginase mutant, wherein said thermophilic L-asparaginase mutant comprises the amino acid sequence set forth in SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, or SEQ ID NO: 9, and wherein said thermophilic L-asparaginase mutant possesses asparaginase enzyme activity. 2. A fermentation method, comprising: inoculating the thermophilic L-asparaginase mutant of claim 1 into a fermentation culture medium in an inoculation amount of 5 to 10 percent, linking a feeding culture medium and ammonia water at a concentration of 40 to 60 percent to acid and alkali inlets of a fermentation tank under fermentation conditions of 500 to 700 rpm and 2 to 6 vvm, setting pH to 7, and feeding when the pH is more than 7. 3. The fermentation method of claim 2 , wherein the fermentation culture medium comprises 45 to 50 g/L glycerol, 30 to 40 g/L peptone, 1 to 2 g/L ammonia chloride, 10 to 20 g/L maize slurry, 2.5 to 3 g/L K 2 HPO 4 , 2 to 2.5 g/L KH 2 PO 4 , 1.5 to 2 g/L MgSO 4 *7H 2 O, and 5 to 10 g/L NaCl, and with a pH adjusted to 7. 4. The fermentation method of claim 2 , wherein the feeding culture medium comprises 40 to 60 percent glycerol and 7 to 8 percent yeast powder. 5. The thermophilic L-asparaginase mutant of claim 1 , wherein the asparaginase enzyme activity of the thermophilic L-asparaginase is greater than wild-type thermophilic L-asparaginase activity measured under identical conditions.
Aspartic acid; Asparagine · CPC title
Preparation of elements or inorganic compounds except carbon dioxide {(recovery of carbon dioxides as by-products C12F3/02)} · CPC title
Asparaginase {(3.5.1.1)} · CPC title
involving hydrolase · CPC title
Asparaginase (3.5.1.1) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.